Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study

BACKGROUND: Previous studies comparing insulin degludec/insulin aspart (IDegAsp) with premixed insulin twice daily among insulin users with type 2 diabetes have not thoroughly investigated differences in the glucose variability and psychological evaluations related to insulin regimen changes. We inv...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetol Metab Syndr
Päätekijät: Fujimoto, Kanta, Iwakura, Toshio, Aburaya, Megumi, Matsuoka, Naoki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097398/
https://ncbi.nlm.nih.gov/pubmed/30127860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-018-0366-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia